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Evaluation of metastases in the submandibular gland in head and
neck malignancy
Abstract
BACKGROUND:: Either excision of the submandibular gland during neck dissection or having the
submandibular gland in radiation field can result in xerostomia, leading to reduced quality of life. The
purpose of this study was to evaluate the prevalence of metastasis to the submandibular gland and to
identify potential risk factors leading to the presence of metastases into the gland. PATIENTS AND
METHODS:: Of 376 patients with head and neck malignancy who were treated between 1999 and 2008,
130 patients underwent a neck dissection, and in total, 171 submandibular glands were removed. The
average age was 61.1 years. RESULTS:: Twenty-three patients (17.7%) revealed some type of
pathology in the submandibular gland such as chronic sialadenitis (15), atrophy (5), tumor infiltration
(5), and intraglandular lymph node (1). In the group with sialadenitis, the mean age was 57.7 years.
Forty-four percent had a pretreatment (radiation, 9%; local resection, 13%; or combined therapy, 22%)
before neck dissection. Of the sialadenitis group, 9 of 12 patients had the primary tumor in the lower
jaw, floor of mouth, or tongue. CONCLUSIONS:: One needs to be aware of the possibility of occult
metastases in level I in oral cavity carcinomas, whereas oropharynx carcinoma constitutes a lower risk
for involvement of lymph node metastases at level I. The excision of the submandibular gland should be
performed in cases with positive lymph nodes at level I and in tumor sites with a high risk of occult
metastasis at level I.
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Abstract 
Background: Either excision of the submandibular gland during neck dissection or having 
the submandibular gland in radiation field can result in xerostomia, leading to reduced quality 
of life. The purpose of this study was to evaluate the prevalence of metastasis to the 
submandibular gland and to identify potential risk factors leading to the presence of 
metastases into the gland.  
Patients and methods: Of 376 patients with  head and neck malignancy who were treated 
between 1999 and 2008, 130 patients underwent a neck dissection, and in total, 171 
submandibular glands were removed. The average age was 61.1 years.  
Results: Twenty-three patients (17.7%) revealed some type of pathology in the 
submandibular gland such as chronic sialadenitis (15), atrophy (5), tumor infiltration (5) and 
intraglandular lymph node (1). In the group with sialadenitis, the mean age was 57.7 years. 
Forty-four percent had a pretreatment (radiation 9%, local resection 13% or combined therapy 
22%) before neck dissection. Of the sialadentitis group, 9 of 12 patients had the primary 
tumor in the lower yaw, floor of mouth or tongue. 
Conclusion: One needs to be aware of the possibility of occult metastases in level I in oral 
cavity carcinomas, whereas oropharynx carcinoma constitutes a lower risk for involvement of 
lymph node metastases in level I. The excision of the submandibular gland should be 
performed in cases with positive lymph nodes at level I and in tumor sites with a high risk of 
occult metastasis at level I.   
Keywords: Metastasis; submandibular gland; head and neck 
 
Excision of the submandibular gland during neck dissection or having the submandibular 
gland in radiation field can result in xerostomia, leading to reduced quality of life. The latter 
was first described by Bergonie 1 in 1911. Radiation with 35 Gy can lead to permanent 
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salivary dysfunction2. The histological hallmarks of radiation-induced damage are acinar 
atrophy and chronic inflammation 3. 
Concerning excision of the submandibular gland, the question arises whether there is a need 
for removing the submandibular gland in neck dissections, because until now, there has been 
no actual treatment that can completely restore the function of the salivary gland following 
radiotherapy. Therefore, we intend to examine retrospectively the involvement of 
submandibular glands in patients who have undergone a neck dissection to explore the 
possibility of preservation of the submandibular gland.  
There are different opinions of the distribution of the lymph nodes in the submandibular 
gland. Spiegel et al4 mentioned that there are no intraparenchymal lymph nodes, whereas 
DiNardo5 and Lim et al6 presented 6 different groups of lymph nodes: preglandular, 
prevascular, retrovascular, retroglandular, deep, and intraglandular.  
DiNardo5 showed in a study of 10 cadavers without evidence of head and neck tumor that 3 
lymph nodes, on average, were found in each submandibular space, with 64% of these lymph 
nodes prevascular and 36% preglandular. In the clinical study with 41 patients with untreated 
head and neck cancer, submandibular node metastases were found in 39% (2 belonged to the 
deep submandibular nodal group). 
With regard to prevascular lymph nodes, the question arises whether it is useful to preserve 
the facial artery during excision of the submandibular gland, particularly when the 
reconstruction follows such as the platysma myocutaneous flap, the lower lip reconstruction 
using Bernard technique, or the facial artery musculocutaneous flap. Talmi  et al7 examined 
overall 81 patients (73 patients underwent neck dissection) but recommended preserving the 
facial artery only in selected cases of malignancy.  
Lim et al6 examining 66 patients with perifacial lymph node dissection, found a 35% 
incidence rate of metastasis to the perifacial lymph node in oral cavity carcinoma and 8% in 
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oropharynx carcinoma. It was striking that in patients without clinically positive level I lymph 
nodes, the occult metastases rate of perifacial node was 27% for oral cavity tumors.  
On the afferent lymphatic side of the submandibular region, superficial oral lymphatic 
capillaries from a mucosal network drain bilaterally to a deep or muscular network ending 
into a plexus around blood vessels. Collecting trunks then receive lymph from mucosal and 
submucosal networks and deliver to the submental, submandibular and carotid triangles. On 
the efferent lymphatic side, lymph can descend from the prevascular and retrovascular nodes, 
drainage occurs along 1 or 2 vessels that follow the facial artery to the posterior belly of the 
digastric and stylohyoid muscles, emptying into the subdigastric or internal nodes. Another 
efferent lymphatic pathway comes from the prevascular and retrovascular nodes descending 
to the anterior facial vein, ultimately emptying in the anterior internal jugular nodes5,8 . 
Involvement of the gland can be caused by direct invasion of the primary tumor, by extension 
of locally involved lymph nodes or by the hematogenous spread of a carcinoma originating 
outside the head and neck. Several cases have been described, for example, breast 9, lung 10, 
and very vascular tumors such as renal cell carcinoma 11. 
Spiegel et al12 showed that the submandibular gland is involved only in cases of ipsilateral 
oral cavity tumors. Perivascular-submandibular lymph node metastasis in squamous cell 
carcinoma of the tongue and floor of mouth seems to have a small incidence. Lim et al6  
revealed perivascular level IB lymph-nodes metastasis in 4 out of 72 necks with tongue 
cancers and 2 out of 27 necks from the floor-of-mouth cancer;  1 deep glandular and 4 pre-
glandular lymph nodes were found. In another study concerning larynx13, only 2% (2/100) of 
the patients with advanced squamous cell carcinoma (T3-T4) had positive lymph nodes in the 
submandibular triangle (Level IB). The rare metastases rate at level I laryngeal and 
hypopharyngeal cancer is supported by Ferlito et al14. But it must always be differentiated 
from floor-of-mouth/tongue cancer and cancer with more posterior origin.  
 4
Only very few studies have been published in the literature concerning the involvement of 
submandibular gland in carcinoma of the head and neck.  Seifert et al10 examined 108 cases of 
metastatic tumors to the parotid and submandibular gland. Ten cases were found in the 
parenchyma of submandibular gland, and 23 cases displayed metastases in the lymph nodes of the 
submandibular gland.  
Spiegel et al12 retrospectively examined in 169 patients with 196 resected submandibular glands 
whether and how the submandibular gland is involved in metastases of squamous cell carcinoma 
of the head and neck. Three submandibular glands showed invasion from locally involved lymph 
nodes, and 6 had direct extension from a primary lesion. 
In 2008,15 201 patients with neck dissection were examined retrospectively. Forty-four cases 
(21.9%) revealed ipsilateral level I metastasis. Two cases (1%) had carcinoma involvement in the 
submandibular gland by direct extension from the primary lesion. There was no isolated 
metastasis or local extension of metastatic lymph nodes found in submandibular gland.  
 
Patients and Methods 
Between January 1999 and December 2008, 376 patients with a diagnosis with malignancy of the 
head and neck were treated in the Department of Craniomaxillofacial and Oral Surgery of the 
University Hospital Zurich (Fig.1).  
 
Fig.1: Overview of the treated patients 
 
Retrospectively, all patients who underwent a neck dissection in a standardized fashion were 
studied. Special attention was paid to TNM status, tumor localization, pathohistology of the 
submandibular glands that were removed as part of neck dissection in regard to pretreatment, 
metastases and tumor infiltration. A study of the involved positive lymph node levels was not 
possible because of not standardized histopathological evaluations being not standardized. 
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 Results 
 
Overview of all Patients that Underwent Neck Dissection 
 
There were 130 patients (53 female, 77 male) who underwent neck dissections where 171 
submandibular glands were removed between January 1999 and December 2008 (Fig.1). Of 
these patients, 38.5% had a pathological status of T2; 45.4% had a pathological N0 status 
(Fig.2). The average age was 60.8 years.  
 
Fig.1: Overview of the treated patients 
Fig.2: Overview of all treated patients that underwent neck dissection 
 
The origin of the tumor was predominantly in the lower jaw (alveolus) (32%), followed by the 
floor of mouth (22%) and tongue (18%) (Fig. 3). 
 
Fig.3: Overview of locations of all treated patients that underwent neck dissection 
 
 
Infiltration of Lymph Node Metastasis into the Submandibular Gland (Lymph  
Node Level) 
 
Twenty-three patients  revealed a pathology in the submandibular gland; chronical sialadenitis 
(12), atrophy (5), tumor infiltration (5) and intraglandular lymph node (1) (Fig. 4). 
 
Fig.4: Determination of patients with submandibular gland pathology in neck dissection 
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In the group of sialadenitis the mean age was 57.7 years. Of these, 44% had a previous 
treatment (radiation 9%, local resection 13% or combined therapy 22%) before neck 
dissection (Fig.5). 
 
Fig.5: Determination of pretreatment in the sialadenitis group 
 
Seventy-five percent (9/12 patients) of the sialadenitis group had the primary tumor in the 
lower jaw/ floor of mouth or tongue (Fig.6) and all patients of the gland atrophy group had the 
primary tumor in the floor of mouth.  
 
Fig.6: Determination of cancer location (with salivary gland pathology) 
 
All patients with tumor infiltration into the submandibular gland or with intraglandular lymph 
node had positive lymph node at level I. 
 
Infiltration of the Tumor into the Submandibular Gland Contralateral Involvement 
 
There was no tumor infiltration or lymph node metastases in the contralateral submandibular 
gland.  
 
 
Metastases to the Submandibular Gland 
 
One female patient revealed an intraglandular lymph node metastasis in 2 years after 
treatment of a pathological T1 tumor of the cheek. 
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 Discussion 
 
Because of poorly developed lymphatics and vasculature of submandibular glands, lymphatic 
metastases are uncommon unlike in the parotid gland.  
Lymph node metastasis surrounding the submandibular gland is relatively common in squamous 
cell carcinoma of the floor of mouth, and it seems to be extremely unusual to find metastasis of 
the submandibular gland. Our results reflect these statements; in only 1 case an intraglandular 
lymph node found. No metastases of head and neck cancer in the contralateral submandibular 
gland were found  in the literature or seen in our study  
It is striking that 44% of the sialadenitis patient group had a previous treatment. Scar tissue 
caused by surgery or radiation can lead to acinar atrophy and fibrosis chronic inflammation, 
particularly in the periductal and intralobular areas.3 But tumor also can cause chronic 
pressure inflammation leading to chronic sialadenitis.  
Only a few of the studies performed emphasized salivary flow rates after submandibular gland 
resection without radiotherapy. Jacob et al 16 compared the salivary flow rates in 29 patients who 
had undergone unilateral gland resection and 8 patients who underwent bilateral gland resection, 
with 29 control patients. Unstimulated and stimulated (paraffin) flow rates were significantly 
lower in both resection groups compared with the control group. Comparing the 2 groups that had 
a resection,, the difference was significant only for stimulated saliva. The result concerning the 
comparison between the group who had a unilateral submandibular gland excision (10 patients) 
and the control group (13 patients) was also supported by Cunning et al. 17 
On the pharmaceutical side, if there is residual salivary function, sialagogues, such as 
pilocarpine hydrochloride, a cholinergic antagonist, have also been mentioned to maximize 
the residual gland function by inducing vasodilatation in the salivary glands via stimulating a 
secretion with similar composition like in normal gland function. 18 
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 Detection Possibilities of Metastases in Submandibular Gland 
 
All patients in our study with tumor infiltration to the ipsilateral submandibular gland or with 
intraglandular lymph node had positive lymph nodes in level I. This supports excluding 
patients with positive lymph nodes in level I from treatment preserving the submandibular 
gland. Alex and Krag19 described in 1993 the first use of sentinel node biopsy for staging head 
and neck cancer. Therefore, the question arises whether it is possible to use this method to 
estimate the involvement of level I lymph node metastases and therefore estimate the risk for 
involvement of the submandibular gland. This technique is still controversially discussed in 
literature14 and is not a standard method.  
 
 
Possibilities for Therapy of Postradiation Xerostomia 
 
Concerning the prevention of postradiation xerostomia, multiple methods have been discussed 
in the literature, for example, shielding the submandibular gland during radiotherapy, but this 
can lead to incomplete treatment. Bourdin20, described in 1982 the transfer of the 
submandibular gland to the submental area in patients with no nodal metastasis of the 
contralateral side. Jha et al 21 transferred the unilateral submandibular gland to the anterior 
submental region and prevented radiation-induced xerostomia up to 83% with a minimum 
follow-up of 2 years. Spiegel et al 12 demonstrated in a rabbit model the possibility of 
transferring the submandibular gland to the groin region and back to the neck while 
maintaining its function and integrity. Most of the patients in studies received postsurgical 
radiation because of positive lymph nodes, therefore long-time results concerning recurrence 
rate are of high interest, but are still not available in most studies.  Al-Qahtani et al21 presented 
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8 patients (with N-status from N2a –N3) with a follow-up of 18 months with a recurrence rate and 
distant metastases rate of 0%.  
 
Other fields of research are salivary gland stem cells and the possibility of cell transplantation 
and tissue engineering of the salivary gland. The latter has revealed that cells adhere to and 
grow on biocompatible materials maintaining acinar cell phenotype and showing α-amylase 
acitivity.22 It is believed that cells in the duct close to the acini provide all cell types required 
for the formation of acini and ducts. 23 But this concept still requires further research. 
 
Conclusion  
In conclusion, this study demonstrated the following results: the preservation of the 
submandibular gland during neck dissection can be performed in special cases of necks 
clinically negative for head and neck carcinoma. One needs to be aware of the possibility of 
occult metastases at level I in oral cavity carcinomas, whereas oropharynx carcinoma 
constitutes a lower risk for involvement of lymph node metastases in level I. The excision of 
the submandibular gland should be performed in cases with positive lymph nodes level I and 
in tumor sites locations with a high risk of occult metastasis at level I.   
Special attention should be paid, on the one hand, to tissue engineering and stem cell research 
and, on the other hand, to improved techniques for detection of malignancy in submandibular 
glands and level I lymph nodes, but there is still a need for further investigations.  
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